Balyasny Asset Management

Balyasny Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Balyasny Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$149M	Buy
2025 Q3	$18.9M	Buy
2025 Q2	$5.71M	Buy
2018 Q2	–	Sell
2018 Q1	$47K	Buy